These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6527244)

  • 1. Quantum chemical approach to the relationship between molecular structure and serotonin receptor binding affinity.
    Gómez-Jeria JS; Morales-Lagos DR
    J Pharm Sci; 1984 Dec; 73(12):1725-8. PubMed ID: 6527244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and activation mechanisms on the LSD/serotonin receptor: the molecular basis of structure activity relationships.
    Weinstein H; Green JP; Osman R; Edwards WD
    NIDA Res Monogr; 1978; (22):333-58. PubMed ID: 101884
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships in the actions of 1-phenyl-piperazines on brain serotonin receptors.
    Fuller RW; Mason NR
    Adv Exp Med Biol; 1981; 133():359-68. PubMed ID: 6172017
    [No Abstract]   [Full Text] [Related]  

  • 5. The electronic and serotonin receptor binding affinity properties of N,N-dimethyltryptamine analogs.
    Glennon RA; Gessner PK
    Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):453-65. PubMed ID: 270770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR of agents involved in serotonin and LSD binding sites.
    Chan YL; Lien EJ; Shih JC
    NIDA Res Monogr; 1978; (22):103-13. PubMed ID: 30904
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serotonin and D-lysergic acid diethylamide receptors in the mammalian brain].
    Vlasova TI; Kirzon MV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (5):5-16. PubMed ID: 6264979
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of a new model of arylpiperazines. 2. Three-dimensional quantitative structure-activity relationships of hydantoin-phenylpiperazine derivatives with affinity for 5-HT1A and alpha 1 receptors. A comparison of CoMFA models.
    López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Fernández E; Schaper KJ
    J Med Chem; 1997 May; 40(11):1648-56. PubMed ID: 9171874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
    Wang CD; Gallaher TK; Shih JC
    Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo receptor binding: attempts to improve specific/non-specific ratios.
    Niehoff DL; Palacios JM; Kuhar MJ
    Life Sci; 1979 Sep; 25(10):819-26. PubMed ID: 491833
    [No Abstract]   [Full Text] [Related]  

  • 12. [Structure of the binding center of the serotonin S2 receptor].
    Kats MM
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (3):19-24. PubMed ID: 3986248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantum chemical studies on molecular determinants for drug action.
    Weinstein H; Osman R; Topiol S; Green JP
    Ann N Y Acad Sci; 1981; 367():434-51. PubMed ID: 6942761
    [No Abstract]   [Full Text] [Related]  

  • 14. N1-methyl-2-[125I]LSD ([125I]MIL), a preferred ligand for serotonin 5-HT2 receptors.
    Hoffman BJ; Karpa MD; Lever JR; Hartig PR
    Eur J Pharmacol; 1985 Mar; 110(1):147-8. PubMed ID: 4007051
    [No Abstract]   [Full Text] [Related]  

  • 15. Photoelectron spectroscopic studies of hallucinogens: the use of ionization potentials in QSAR.
    Domelsmith LN; Houk KN
    NIDA Res Monogr; 1978; (22):423-40. PubMed ID: 101887
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantum chemical studies on drug actions. 3. Correlation of hallucinogenic and anti-serotonin activity of lysergic acid derivatives with quantum chemical data.
    Kumbar M; Sankar DV
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):65-100. PubMed ID: 4734018
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and serotonin receptor affinities of a series of enantiomers of alpha-methyltryptamines: evidence for the binding conformation of tryptamines at serotonin 5-HT1B receptors.
    Nichols DE; Lloyd DH; Johnson MP; Hoffman AJ
    J Med Chem; 1988 Jul; 31(7):1406-12. PubMed ID: 3385733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative receptor autoradiography: application to the study of multiple serotonin receptors in rat cortex.
    Palacios JM
    Adv Biochem Psychopharmacol; 1983; 37():455-63. PubMed ID: 6637602
    [No Abstract]   [Full Text] [Related]  

  • 20. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
    Monsma FJ; Shen Y; Ward RP; Hamblin MW; Sibley DR
    Mol Pharmacol; 1993 Mar; 43(3):320-7. PubMed ID: 7680751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.